StockWatch
·

Borosil Scientific Ltd

BSE: 544184

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
106.81
+4.0%+4.9%
Expenditure
97.88
+4.8%+6.7%
Net Profit
6.25
-8.7%-16.9%
OPM %
10.75%
-0.33pp-1.56pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0037.5375.06112.60150.13Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Borosil Scientific Q2FY27: PAT +86% YoY to ₹5.3 Cr, margin expands as pharma losses narrow

lab glass equipment · pharma packaging · margin expansion

ResultsQ2 FY2728 Oct 20263 minIndustrials & Infra

Borosil Scientific: consolidated PAT turns profitable YoY at ₹4.36 Cr, slows QoQ

lab glassware · yoy turnaround · qoq slowdown

ResultsQ1 FY2703 Aug 20263 minIndustrials & Infra
Latest

Corporate Events

Board MeetingBOROSCI
2026
28Oct

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingBOROSCI
2026
25Sep

Board Meeting

The Annual General Meeting (AGM) is scheduled to be held on …

BSE Filing ↗
Board MeetingBOROSCI
2026
22Sep

Board Meeting

The Board of Directors approved the proposal for expansion o…

BSE Filing ↗
Board MeetingBOROSCI
2026
3Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingBOROSCI
2026
11Feb

Board Meeting

consider and approve the Unaudited Financial Results (Standa…

BSE Filing ↗
Board MeetingBOROSCI
2025
11Aug

Board Meeting

Board Meeting Intimation, Unaudited Financial Results (Stand…

BSE Filing ↗
Board MeetingBOROSCI
2025
11Feb

Board Meeting

Consider and approve Unaudited Financial Results

BSE Filing ↗
Board MeetingBOROSCI
2024
12Nov

Board Meeting

Consider and approve the Unaudited Standalone & Consolidated…

BSE Filing ↗
Board MeetingBOROSCI
2024
13Aug

Board Meeting

Consider and approve Unaudited Standalone & Consolidated Fin…

BSE Filing ↗